From: National survey and point prevalence study of sedation practice in UK critical care
Reported frequency of use, n (%) | ||||
---|---|---|---|---|
Very frequently/frequently | Occasionally/rarely | Never | Not reported | |
Sedative agent | ||||
Propofol | 210 (98.1) | 2 (0.9) | 0 (0) | 2 (0.9) |
Midazolam | 69 (32.2) | 130 (60.7) | 11 (5.1) | 4 (1.9) |
Diazepam | 4 (1.9) | 96 (44.9) | 105 (49.1) | 9 (4.2) |
Lorazepam | 2 (0.9) | 120 (56.1) | 83 (38.8) | 9 (4.2) |
Clonidine | 70 (32.7) | 129 (60.3) | 8 (3.7) | 7 (3.3) |
Dexmedetomidine | 22 (10.3) | 57 (26.6) | 127 (59.3) | 8 (3.7) |
Haloperidol | 79 (36.9) | 115 (53.7) | 13 (6.1) | 7 (3.3) |
Atypical anti-psychotica | 15 (7.0) | 94 (43.9) | 89 (41.6) | 16 (7.5) |
Other | 26 (12.1) | 12 (5.6) | – | 176 (82.2) |
Analgesic agent | ||||
Morphine | 90 (42.1) | 114 (53.3) | 6 (2.8) | 4 (1.9) |
Fentanyl | 77 (36.0) | 89 (41.6) | 41 (19.2) | 7 (3.3) |
Alfentanil | 110 (51.4) | 53 (24.8) | 46 (21.5) | 5 (2.3) |
Remifentanil | 72 (33.6) | 106 (49.5) | 32 (15.0) | 4 (1.9) |
Ketamine | 1 (0.5) | 177 (82.7) | 28 (13.1) | 8 (3.7) |
Other | 3 (1.4) | 9 (4.2) | – | 202 (94.4) |
Sedative/analgesic delivery regimen | ||||
Single sedative agent | 47 (22.0) | 142 (66.4) | 4 (1.9) | 21 (9.8) |
Sedative(s) in combination with one or more analgesic agents | 207 (96.7) | 4 (1.9) | 0 (0) | 3 (1.4) |
Multiple sedatives together | 23 (10.8) | 163 (76.2) | 5 (2.3) | 23 (10.7) |